Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;13(4):246-57.
doi: 10.1038/nrc3458. Epub 2013 Mar 7.

The Hippo Pathway and Human Cancer

Affiliations
Review

The Hippo Pathway and Human Cancer

Kieran F Harvey et al. Nat Rev Cancer. .

Abstract

The Hippo pathway controls organ size in diverse species, whereas pathway deregulation can induce tumours in model organisms and occurs in a broad range of human carcinomas, including lung, colorectal, ovarian and liver cancer. Despite this, somatic or germline mutations in Hippo pathway genes are uncommon, with only the upstream pathway gene neurofibromin 2 (NF2) recognized as a bona fide tumour suppressor gene. In this Review, we appraise the evidence for the Hippo pathway as a cancer signalling network, and discuss cancer-relevant biological functions, potential mechanisms by which Hippo pathway activity is altered in cancer and emerging therapeutic strategies.

Similar articles

See all similar articles

Cited by 571 articles

See all "Cited by" articles

References

    1. Cancer Cell. 2009 Nov 6;16(5):425-38 - PubMed
    1. Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9767-72 - PubMed
    1. Cancer Res. 2005 Sep 15;65(18):8090-5 - PubMed
    1. Nature. 1975 Dec 11;258(5535):487-90 - PubMed
    1. Curr Biol. 2006 Nov 7;16(21):2090-100 - PubMed

Substances

LinkOut - more resources

Feedback